Ulrika Wilhelmsson Selected Research

Glial Fibrillary Acidic Protein

1/2019	The role of GFAP and vimentin in learning and memory.
12/2014	Beneficial effects of gfap/vimentin reactive astrocytes for axonal remodeling and motor behavioral recovery in mice after stroke.
1/2014	Synemin is expressed in reactive astrocytes and Rosenthal fibers in Alexander disease.
10/2013	Astrocytoma grade IV (glioblastoma multiforme) displays 3 subtypes with unique expression profiles of intermediate filament proteins.
1/2013	Axonal regeneration after sciatic nerve lesion is delayed but complete in GFAP- and vimentin-deficient mice.
1/2013	Plasticity response in the contralesional hemisphere after subtle neurotrauma: gene expression profiling after partial deafferentation of the hippocampus.
2/2011	Reactive glial cells: increased stiffness correlates with increased intermediate filament expression.
10/2007	Increased neurogenesis and astrogenesis from neural progenitor cells grafted in the hippocampus of GFAP-/- Vim-/- mice.
9/2007	14-3-3 expression in denervated hippocampus after entorhinal cortex lesion assessed by culture-derived isotope tags in quantitative proteomics.
6/2007	Attenuated glial reactions and photoreceptor degeneration after retinal detachment in mice deficient in glial fibrillary acidic protein and vimentin.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ulrika Wilhelmsson Research Topics

Disease

13	Gliosis 10/2019 - 01/2007
5	Stroke (Strokes) 12/2021 - 11/2006
5	Ischemia 01/2019 - 03/2006
4	Inflammation (Inflammations) 01/2019 - 03/2006
3	Astrocytoma (Pilocytic Astrocytoma) 10/2013 - 05/2003
3	Hypertrophy 01/2007 - 05/2004
2	Atherosclerosis 01/2019 - 11/2018
2	Chromosomal Instability (Chromosome Stability) 01/2019 - 07/2018
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2014 - 10/2007
2	Neoplasms (Cancer) 10/2013 - 05/2003
2	Retinal Detachment (Retinal Detachments) 08/2008 - 06/2007
1	Atrophy 12/2021
1	Neuroinflammatory Diseases 12/2021
1	Insulin Resistance 12/2021
1	Weight Loss (Weight Reduction) 12/2021
1	Lung Injury 01/2019
1	Body Weight (Weight, Body) 01/2019
1	Fibrosis (Cirrhosis) 01/2019
1	Wounds and Injuries (Trauma) 07/2018
1	Alexander Disease (Alexander's Disease) 01/2014
1	Glioblastoma (Glioblastoma Multiforme) 10/2013
1	Wallerian Degeneration 01/2013
1	Amyloid Plaque 01/2013
1	Alzheimer Disease (Alzheimer's Disease) 01/2013
1	Sciatic Neuropathy (Lesion of Sciatic Nerve) 01/2013
1	Ischemic Stroke 08/2010
1	Hypoxia (Hypoxemia) 08/2010
1	Brain Ischemia (Cerebral Ischemia) 03/2008
1	Infarction (Infarctions) 03/2008
1	Retinal Diseases 06/2007
1	Central Nervous System Diseases (CNS Diseases) 08/2003
1	Anaplasia 05/2003

Drug/Important Bio-Agent (IBA)

19	VimentinIBA 01/2019 - 05/2004
14	Glial Fibrillary Acidic ProteinIBA 01/2019 - 05/2003
9	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2007
7	Intermediate Filament ProteinsIBA 01/2019 - 05/2004
5	NestinIBA 10/2013 - 11/2006
3	Complement System Proteins (Complement)IBA 10/2019 - 03/2006
3	desmuslin (synemin)IBA 01/2014 - 04/2007
2	Glucose (Dextrose)FDA LinkGeneric 12/2021 - 01/2019
2	Serine (L-Serine)FDA Link 01/2019 - 07/2018
2	Plasminogen Activator Inhibitor 1IBA 08/2010 - 03/2008
2	Retinaldehyde (Retinal)IBA 10/2007 - 06/2007
1	ParvalbuminsIBA 12/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Oxygen (Dioxygen)IBA 01/2019
1	LipidsIBA 11/2018
1	Chondroitin Sulfate ProteoglycansIBA 12/2014
1	Rose BengalIBA 12/2014
1	Crystallins (Crystallin)IBA 01/2014
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2014
1	Biological ProductsIBA 10/2013
1	thrombospondin 4IBA 01/2013
1	Amyloid (Amyloid Fibrils)IBA 01/2013
1	Interleukin-10 (Interleukin 10)IBA 08/2010
1	Peptide Hydrolases (Proteases)FDA Link 08/2010
1	Plasminogen Activators (Plasminogen Activator)IBA 08/2010
1	Messenger RNA (mRNA)IBA 08/2010
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2010
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 08/2010
1	SerpinsIBA 08/2010
1	Interleukin-6 (Interleukin 6)IBA 08/2010
1	CytokinesIBA 08/2010
1	Transforming Growth Factor alpha (TGF-alpha)IBA 08/2010
1	Transforming Growth Factor beta (TGF-beta)IBA 08/2010
1	Serine Proteases (Serine Protease)IBA 08/2010
1	Glutamic Acid (Glutamate)FDA Link 03/2008
1	Endothelin B ReceptorIBA 03/2008
1	IsotopesIBA 09/2007
1	Protein Isoforms (Isoforms)IBA 09/2007
1	ProteomeIBA 09/2007
1	14-3-3 Proteins (14-3-3 Protein)IBA 09/2007
1	Neuroprotective AgentsIBA 01/2007
1	Ethylnitrosourea (N-Ethyl-N-nitrosourea)IBA 05/2003

Therapy/Procedure

2	Transplantation 01/2018 - 08/2003
1	Nephrectomy 01/2019
1	Axotomy 01/2013
1	Therapeutics 08/2003